Table 1 Baseline characteristics of the study participants

Age, years:

Mean ± SD^a

36.3 ±9.2

34.8 ±6.9

0.29

Gender, number (%):

Male

53 (79.1)

59 (86.8)

0.24

Female

14 (20.9)

09 (13.2)

BMI^b, kg/m²:

Mean ± SD

18.2 ±2.7

18.4 ±2.7

0.57

Haemoglobin, g/dL:

Mean ± SD

10.0 ±1.9

10.4 ±1.8

0.27

CD4 count, cells/mm³:

Median (Range)

137 (20–506)

139 (7–588)

0.90

log₁₀ viral load/ml:

Median (Range)

5.52 (2.60–6.58)

5.19 (2.76–6.76)

0.43

WHO Staging of HIV disease, number (%):

Stage-3

03 (4.5)

02 (2.9)

0.64

Stage-4

64 (95.5)

66 (97.1)

Type of Tuberculosis, number (%):

PTB^c

16 (23.9)

19 (27.9)

0.06

EPTB^d

31 (46.3)

40 (58.8)

Disseminated/Miliary TB

20 (29.8)

09 (13.3)

Category of ATT^e, number (%):

Category I

52 (77.6)

55 (80.9)

0.64

Category II

15 (22.4)

13 (19.1)

ATT-ART^f gap, days:

Median (Range)

27 (11–85)

26 (04–93)

0.92